S&P 500   4,158.24
DOW   33,212.96
QQQ   309.10
S&P 500   4,158.24
DOW   33,212.96
QQQ   309.10
S&P 500   4,158.24
DOW   33,212.96
QQQ   309.10
S&P 500   4,158.24
DOW   33,212.96
QQQ   309.10

Magellan Health (MGLN) Stock Forecast, Price & News

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
50-Day Range
52-Week Range
Average Volume
238,670 shs
Market Capitalization
$2.50 billion
P/E Ratio
Dividend Yield

Receive MGLN News and Ratings via Email

Sign-up to receive the latest news and ratings for Magellan Health and its competitors with MarketBeat's FREE daily newsletter.

Magellan Health logo

About Magellan Health

Magellan Health, Inc. engages in the business of healthcare management. It operates through the following segments: Healthcare, Pharmacy Management and Corporate. The Healthcare segment includes the Behavioral & Specialty Health reporting unit, which provides carve-out management services for behavioral health, employee assistance plans, and other areas of specialty healthcare. The Pharmacy Management segment comprises of services that provide clinical and financial management of pharmaceuticals paid under both the medical and the pharmacy benefit. The Corporate segment covers amounts not allocated to the Healthcare and Pharmacy Management segments. The company was founded in 1969 and is headquartered in Phoenix, AZ.


See More Headlines

Industry, Sector and Symbol

Managed Health Care
Current Symbol
Year Founded

Sales & Book Value

Annual Sales
$4.58 billion
Cash Flow
$5.57 per share
Book Value
$73.03 per share


Net Income
$382.33 million
Pretax Margin




Free Float
Market Cap
$2.50 billion

Company Calendar

Last Earnings
Fiscal Year End


Overall MarketRank

1.95 out of 5 stars

Medical Sector

641st out of 1,431 stocks

Hospitals Industry

3rd out of 5 stocks

Analyst Opinion: 0.0Community Rank: 4.1Dividend Strength: 0.0Insider Behavior: 2.5Valuation: 3.1 5 -4 -3 -2 -1 -

Magellan Health (NASDAQ:MGLN) Frequently Asked Questions

How were Magellan Health's earnings last quarter?

Magellan Health, Inc. (NASDAQ:MGLN) announced its quarterly earnings data on Friday, November, 5th. The company reported $0.03 EPS for the quarter, missing analysts' consensus estimates of $0.37 by $0.34. The firm earned $1.25 billion during the quarter, compared to analyst estimates of $1.21 billion. Magellan Health had a net margin of 6.26% and a trailing twelve-month return on equity of 1.81%. Magellan Health's revenue for the quarter was up 7.2% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.08 EPS.
View Magellan Health's earnings history

Who are Magellan Health's key executives?
Magellan Health's management team includes the following people:
  • Kenneth J. Fasola, Chief Executive Officer & Director
  • James E. Murray, President & Chief Operating Officer
  • David Patrick Bourdon, Chief Financial Officer
  • Caroline Carney, Chief Medical Officer
  • Jeffrey N. West, Principal Accounting Officer, SVP & Controller
What is Kenneth J. Fasola's approval rating as Magellan Health's CEO?

31 employees have rated Magellan Health CEO Kenneth J. Fasola on Glassdoor.com. Kenneth J. Fasola has an approval rating of 83% among Magellan Health's employees.

Who are some of Magellan Health's key competitors?
What other stocks do shareholders of Magellan Health own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Magellan Health investors own include Energy Transfer (ET), General Motors (GM), NVIDIA (NVDA), Boeing (BA), Netflix (NFLX), UnitedHealth Group (UNH), Broadcom (AVGO), Mastercard (MA), Ford Motor (F) and Overstock.com (OSTK).

What is Magellan Health's stock symbol?

Magellan Health trades on the NASDAQ under the ticker symbol "MGLN."

Who are Magellan Health's major shareholders?

Magellan Health's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Ancora Advisors LLC (0.00%), Concourse Financial Group Securities Inc. (0.00%) and Simplex Trading LLC (0.00%). Company insiders that own Magellan Health stock include Jeffrey N West and Mostafa Kamal.
View institutional ownership trends for Magellan Health

Which institutional investors are selling Magellan Health stock?

MGLN stock was sold by a variety of institutional investors in the last quarter, including Simplex Trading LLC, and Ancora Advisors LLC.
View insider buying and selling activity for Magellan Health
or view top insider-selling stocks.

What is Magellan Health's stock price today?

One share of MGLN stock can currently be purchased for approximately $94.99.

How much money does Magellan Health make?

Magellan Health has a market capitalization of $2.50 billion and generates $4.58 billion in revenue each year. The company earns $382.33 million in net income (profit) each year or $11.47 on an earnings per share basis.

How many employees does Magellan Health have?

Magellan Health employs 9,000 workers across the globe.

What is Magellan Health's official website?

The official website for Magellan Health is www.magellanhealth.com.

How can I contact Magellan Health?

Magellan Health's mailing address is 4801 E. Washington Street, Phoenix AZ, 85034. The company can be reached via phone at (800) 642-1716, via email at [email protected], or via fax at 860-507-1990.

This page was last updated on 5/29/2022 by MarketBeat.com Staff


Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.